DexCom (DXCM), a prominent player in the glucose monitoring market, reported first-quarter fiscal 2011 loss per share of 19 cents, a penny higher thanĀ the Zacks Consensus Estimate while...(
read more)
DexCom (DXCM) reported third-quarter 2010 loss per share of 23 cents, matching the Zacks Consensus Estimate and improving from the year-ago loss of 29...(
read more)
San Diego, California based medical device manufacturer DexCom, Inc. (Nasdaq: DXCM) late on Thursday released financial results that sent the company's stock price plummeting during after hours trading.
DexCom, Inc reported a 3rd...(
read more)